Record Information |
---|
Version | 1.0 |
---|
Created at | 2021-01-06 06:36:17 UTC |
---|
Updated at | 2021-07-15 17:36:06 UTC |
---|
NP-MRD ID | NP0021343 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Acetomycin |
---|
Provided By | NPAtlas |
---|
Description | Acetomycin is found in Streptomyces ramulosus. It was first documented in 1985 (PMID: 4093332). Based on a literature review a small amount of articles have been published on Acetomycin (PMID: 17305349) (PMID: 1309871) (PMID: 1965311). |
---|
Structure | [H]C([H])([H])C(=O)O[C@@]1([H])OC(=O)[C@@](C(=O)C([H])([H])[H])(C([H])([H])[H])[C@]1([H])C([H])([H])[H] InChI=1S/C10H14O5/c1-5-8(14-7(3)12)15-9(13)10(5,4)6(2)11/h5,8H,1-4H3/t5-,8+,10+/m1/s1 |
---|
Synonyms | Value | Source |
---|
3-Acetyl-5-(acetyloxy)dihydro-3,4-dimethyl-2(3H)furanone | MeSH | 4-Acetyl-3,4-dimethyl-5-oxooxolan-2-yl acetic acid | Generator |
|
---|
Chemical Formula | C10H14O5 |
---|
Average Mass | 214.2170 Da |
---|
Monoisotopic Mass | 214.08412 Da |
---|
IUPAC Name | (2S,3S,4S)-4-acetyl-3,4-dimethyl-5-oxooxolan-2-yl acetate |
---|
Traditional Name | (2S,3S,4S)-4-acetyl-3,4-dimethyl-5-oxooxolan-2-yl acetate |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC1C(OC(C)=O)OC(=O)C1(C)C(C)=O |
---|
InChI Identifier | InChI=1S/C10H14O5/c1-5-8(14-7(3)12)15-9(13)10(5,4)6(2)11/h5,8H,1-4H3 |
---|
InChI Key | OYMZTORLGBISLR-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | This compound belongs to the class of organic compounds known as acylals. These are diesters of geminal diols. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Carboxylic acid derivatives |
---|
Direct Parent | Acylals |
---|
Alternative Parents | |
---|
Substituents | - Acylal
- Gamma butyrolactone
- Dicarboxylic acid or derivatives
- Tetrahydrofuran
- Lactone
- Ketone
- Oxacycle
- Organoheterocyclic compound
- Acetal
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic heteromonocyclic compound
|
---|
Molecular Framework | Aliphatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Uhr H, Zeeck A, Clegg W, Egert E, Fuhrer H, Peter HH: The structure of acetomycin. Spectroscopic characterization and X-ray analysis of a bromo derivative. J Antibiot (Tokyo). 1985 Dec;38(12):1684-90. doi: 10.7164/antibiotics.38.1684. [PubMed:4093332 ]
- Calad SA, Woerpel KA: Formation of chiral quaternary carbon stereocenters using silylene transfer reactions: enantioselective synthesis of (+)-5-epi-acetomycin. Org Lett. 2007 Mar 15;9(6):1037-40. doi: 10.1021/ol063072p. Epub 2007 Feb 17. [PubMed:17305349 ]
- Villani-Price D, Yang DC, Walsh RE, Fretland DJ, Keith RH, Kocan G, Kachur JF, Gaginella TS, Tsai BS: Multiple actions of the leukotriene B4 receptor antagonist SC-41930. J Pharmacol Exp Ther. 1992 Jan;260(1):187-91. [PubMed:1309871 ]
- Fretland DJ, Widomski DL, Zemaitis JM, Walsh RE, Levin S, Djuric SW, Shone RL, Tsai BS, Gaginella TS: Inflammation of guinea pig dermis. Effects of leukotriene B4 receptor antagonist, SC-41930. Inflammation. 1990 Dec;14(6):727-39. doi: 10.1007/BF00916375. [PubMed:1965311 ]
|
---|